Showing results (321-330 of 360) with videos related to

Sort By:
Pageof 36
International Journal of Chronic Obstructive Pulmonary Disease|December 6, 2023
Respiratory Symptoms, Disease Burden, and Quality of Life in Australian Adults According to GOLD Spirometry Grades: Data from the BOLD Australia StudyYijun Zhou, Maria R Ampon, Michael J Abramson, et al.
ERJ Open Research|August 23, 2023
Clinical characteristics of adults with self-reported diagnosed asthma and/or COPD: data from the BOLD Australia StudyYijun Zhou, Maria R Ampon, Michael J Abramson, et al.
British Journal of Pharmacology|January 1, 1988
Zolantidine (SK&F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonistC R Calcutt, C R Ganellin, R Griffiths, et al.
Chronic Respiratory Disease|December 21, 2023
Risk factors and clinical characteristics of breathlessness in Australian adults: Data from the BOLD Australia studyYijun Zhou, Maria R Ampon, Michael J Abramson, et al.
BMC Pulmonary Medicine|June 21, 2022
Implementing evidence into practice to improve chronic lung disease management in Indigenous Australians: the breathe easy, walk easy, lungs for life (BE WELL) project (protocol)David P Meharg, Christine R Jenkins, Graeme P Maguire, et al.
Neuroimage|February 5, 2021
Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [11C]-ABP688 PET imaging in healthy volunteersJohannes Streffer, Valerie Treyer, Alfred Buck, et al.
Neurology|June 1, 1997
Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography studyU Roelcke, L Kappos, J Lechner-Scott, et al.
Expert Systems with Applications|August 13, 2019
A practical computerized decision support system for predicting the severity of Alzheimer's disease of an individualMagda Bucholc, Xuemei Ding, Haiying Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductaseD Amin, R Z Rutledge, S N Needle, et al.
Trials|January 29, 2016
Improving delivery of secondary prophylaxis for rheumatic heart disease in remote Indigenous communities: study protocol for a stepped-wedge randomised trialAnna P Ralph, Clancy Read, Vanessa Johnston, et al.
Pageof 36